Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE])

This publication has 12 references indexed in Scilit:

• Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin
  American Heart Journal, 2001
• Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes
  American Heart Journal, 2001
• Antithrombotic Agents in Coronary Artery Disease
  Chest, 2001
• Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice
  The Lancet, 2001
• Effects of Prior Aspirin and Anti-Ischemic Therapy on Outcome of Patients With Unstable Angina 11This study was supported by Biogen, Inc., Cambridge, Massachusetts. Manuscript received July 28, 1997; revised manuscript received and accepted December 1, 1997.
  The American Journal of Cardiology, 1998
• Does Aspirin Consumption Affect the Presentation or Severity of Acute Myocardial Infarction?
  Archives of internal medicine (1960), 1995
• Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
  Circulation, 1994
• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989
• WHO MONICA Project: Objectives and Design
  International Journal of Epidemiology, 1989
• Randomised trial of prophylactic daily aspirin in British male doctors
  BMJ, 1988